230 related articles for article (PubMed ID: 10359881)
1. Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen.
Terrien MH; Rahm F; Fellrath JM; Spertini F
J Allergy Clin Immunol; 1999 Jun; 103(6):1025-30. PubMed ID: 10359881
[TBL] [Abstract][Full Text] [Related]
2. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
3. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms.
Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB
J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the antiobstructive effect of fexofenadine on nasal allergy challenge in patients with seasonal allergic rhinitis.
Mösges R; Lehmacher W; Pasch N; Vent J
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):181-90. PubMed ID: 20232572
[TBL] [Abstract][Full Text] [Related]
5. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis.
Horak F; Stübner P; Zieglmayer R; Kavina A; De Vos C; Burtin B; Donnelly F
Int Arch Allergy Immunol; 2001 May; 125(1):73-9. PubMed ID: 11385291
[TBL] [Abstract][Full Text] [Related]
6. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
7. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
Hilberg O
Allergy; 1995 Aug; 50(8):683-8. PubMed ID: 7503405
[TBL] [Abstract][Full Text] [Related]
8. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
Ciprandi G; Cirillo I; Vizzaccaro A
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
LaForce CF; Corren J; Wheeler WJ; Berger WE;
Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
Sussman GL; Mason J; Compton D; Stewart J; Ricard N
J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.
Bensch GW; Nelson HS; Borish LC
Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a new antihistaminic and antiallergic compound KW 4679 with terfenadine and placebo on skin and nasal provocation in atopic individuals.
Hamilton SA; Duddle J; Herdman MJ; Trigg CJ; Davies RJ
Clin Exp Allergy; 1994 Oct; 24(10):955-9. PubMed ID: 7842365
[TBL] [Abstract][Full Text] [Related]
14. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
[TBL] [Abstract][Full Text] [Related]
15. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
Simpson K; Jarvis B
Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
[TBL] [Abstract][Full Text] [Related]
16. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.
Wilson AM; Haggart K; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2002 Oct; 32(10):1504-9. PubMed ID: 12372132
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis.
Berkowitz RB; Braker S; Lutz C; Jones P; Meeves S; Qiu C; Varghese ST; Georges G
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):327-33. PubMed ID: 16498855
[TBL] [Abstract][Full Text] [Related]
18. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
[TBL] [Abstract][Full Text] [Related]
19. Effects of terfenadine and pseudoephedrine, alone and in combination in a nasal provocation test and in perennial rhinitis.
Henauer S; Seppey M; Huguenot C; Pécoud A
Eur J Clin Pharmacol; 1991; 41(4):321-4. PubMed ID: 1804647
[TBL] [Abstract][Full Text] [Related]
20. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
